134 related articles for article (PubMed ID: 2605106)
1. Quantitative magnetic resonance imaging in autologous bone marrow transplantation for Hodgkin's disease.
Smith SR; Williams CE; Edwards RH; Davies JM
Br J Cancer; 1989 Dec; 60(6):961-5. PubMed ID: 2605106
[TBL] [Abstract][Full Text] [Related]
2. Quantitative magnetic resonance studies of lumbar vertebral marrow in patients with refractory or relapsed Hodgkin's disease.
Smith SR; Williams CE; Edwards RH; Davies JM
Ann Oncol; 1991 Feb; 2 Suppl 2():39-42. PubMed ID: 2049319
[TBL] [Abstract][Full Text] [Related]
3. Detection of bone marrow abnormalities in patients with Hodgkin's disease by T1 mapping of MR images of lumbar vertebral bone marrow.
Smith SR; Roberts N; Percy DF; Edwards RH
Br J Cancer; 1992 Feb; 65(2):246-51. PubMed ID: 1739624
[TBL] [Abstract][Full Text] [Related]
4. Detection and significance of bone marrow infiltration at the time of autologous bone marrow transplantation in Hodgkin's disease.
Chopra R; Wotherspoon AC; Blair S; McMillan AK; Mills W; Fielding AK; Linch DC; Goldstone AH
Br J Haematol; 1994 Jul; 87(3):647-9. PubMed ID: 7993812
[TBL] [Abstract][Full Text] [Related]
5. GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation.
Brandwein JM; Nayar R; Baker MA; Sutton DM; Scott JG; Sutcliffe SB; Keating A
Exp Hematol; 1991 Mar; 19(3):191-5. PubMed ID: 1995310
[TBL] [Abstract][Full Text] [Related]
6. Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Majolino I; Pearce R; Taghipour G; Goldstone AH
J Clin Oncol; 1997 Feb; 15(2):509-17. PubMed ID: 9053472
[TBL] [Abstract][Full Text] [Related]
7. Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment.
Douay L; Gorin NC; Mary JY; Lemarie E; Lopez M; Najman A; Stachowiak J; Giarratana MC; Baillou C; Salmon C
Exp Hematol; 1986 Jun; 14(5):358-65. PubMed ID: 3519263
[TBL] [Abstract][Full Text] [Related]
8. Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma.
Smith TJ; Hillner BE; Schmitz N; Linch DC; Dreger P; Goldstone AH; Boogaerts MA; Ferrant A; Link H; Zander A; Yanovich S; Kitchin R; Erder MH
J Clin Oncol; 1997 Jan; 15(1):5-10. PubMed ID: 8996118
[TBL] [Abstract][Full Text] [Related]
9. Comparative diagnostic accuracy of magnetic resonance imaging and immunoscintigraphy for detection of bone marrow involvement in patients with malignant lymphoma.
Altehoefer C; Blum U; Bathmann J; Wüstenberg C; Uhrmeister P; Laubenberger J; Lange W; Schwarzkopf J; Moser E; Langer M
J Clin Oncol; 1997 May; 15(5):1754-60. PubMed ID: 9164182
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow Transplantation.
Milpied N; Fielding AK; Pearce RM; Ernst P; Goldstone AH
J Clin Oncol; 1996 Apr; 14(4):1291-6. PubMed ID: 8648386
[TBL] [Abstract][Full Text] [Related]
11. Autologous transplantation in poor risk Hodgkin's disease using high dose melphalan/etoposide conditioning with non-cryopreserved marrow rescue. The Newcastle and Northern Region Lymphoma Group.
Taylor PR; Jackson GH; Lennard AL; Lucraft H; Proctor SJ
Br J Cancer; 1993 Feb; 67(2):383-7. PubMed ID: 8431371
[TBL] [Abstract][Full Text] [Related]
12. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
13. Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein versus granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for non-Hodgkin's lymphoma: results of a randomized double-blind trial.
Vose JM; Pandite AN; Beveridge RA; Geller RB; Schuster MW; Anderson JE; LeMaistre CF; Ahmed T; Granena A; Keating A; Fernandez Ranada JM; Stiff PJ; Tabbara I; Longo W; Copelan EA; Nichols C; Smith A; Topolsky DL; Bierman PJ; Lebsack ME; Lange M; Garrison L
J Clin Oncol; 1997 Apr; 15(4):1617-23. PubMed ID: 9193361
[TBL] [Abstract][Full Text] [Related]
14. G-CSF primed peripheral blood progenitor cells in autologous bone marrow transplantation: parameters affecting bone marrow engraftment.
Bolwell BJ; Fishleder A; Andresen SW; Lichtin AE; Koo A; Yanssens T; Burwell R; Baucco P; Green R
Bone Marrow Transplant; 1993 Dec; 12(6):609-14. PubMed ID: 7511016
[TBL] [Abstract][Full Text] [Related]
15. Autologous bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma.
Kessinger A; Nademanee A; Forman SJ; Armitage JO
Hematol Oncol Clin North Am; 1990 Jun; 4(3):577-87. PubMed ID: 1972701
[TBL] [Abstract][Full Text] [Related]
16. Concomitant and sequential administration of recombinant human granulocyte colony-stimulating factor and recombinant human interleukin-3 to accelerate hematopoietic recovery after autologous bone marrow transplantation for malignant lymphoma.
Lemoli RM; Rosti G; Visani G; Gherlinzoni F; Miggiano MC; Fortuna A; Zinzani P; Tura S
J Clin Oncol; 1996 Nov; 14(11):3018-25. PubMed ID: 8918500
[TBL] [Abstract][Full Text] [Related]
17. Intensive chemotherapy and autologous peripheral blood stem cell transplantation in a patient with persistent marrow involvement with Hodgkin's disease.
Phillips GL; Reece DE; Lerner KG; Connors JM
Bone Marrow Transplant; 1990 Jul; 6(1):45-7. PubMed ID: 1975204
[TBL] [Abstract][Full Text] [Related]
18. [Autologous bone marrow transplantation for the treatment of malignant lymphoma in adults].
Da WM; Zhong JT; Huang YS
Zhonghua Nei Ke Za Zhi; 1992 Oct; 30(10):640-2, 660. PubMed ID: 1582346
[TBL] [Abstract][Full Text] [Related]
19. Prognostic importance of magnetic resonance imaging in bone marrow involvement of Hodgkin disease.
Varan A; Cila A; Büyükpamukçu M
Med Pediatr Oncol; 1999 Apr; 32(4):267-71. PubMed ID: 10102020
[TBL] [Abstract][Full Text] [Related]
20. Detection and significance of pulmonary Hodgkin's disease at autologous bone marrow transplantation.
Grimwade DJ; Chopra R; King A; Shaw P; Pearce R; Linch DC; Goldstone AH
Bone Marrow Transplant; 1994 Feb; 13(2):173-9. PubMed ID: 8205087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
